drugset / Trial / NCT03751488
A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will look at the Characteristics of LY03010 Versus INVEGA SUSTENNA® in the blood of Schizophrenia Patients
Timeline
- Start
- 2018-12-12
- Primary completion
- 2019-07-24
- Completion
- 2019-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY03010 | Unknown | 117 mg | — |
| Subject | LY03010 | Unknown | 156 mg | — |
| Subject | LY03010 | Unknown | 351 mg | — |
| Comparator | paliperidone palmitate | Unknown | 156 mg | — |